Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Accord Healthcare Limited, Sage House, 319, Pinner Road, North Harrow, Middlesex HA1 4 HF, United Kingdom
Aceclofenac 100 mg film-coated Tablets.
| Pharmaceutical Form |
|---|
|
100 mg: Film-coated tablet. White to off-white, round shaped, biconvex, film-coated tablet debossed with “100” on one side and plain on the other side. |
Each film-coated tablet contains 100 mg of Aceclofenac.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Aceclofenac |
Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins. |
| List of Excipients |
|---|
|
Core Tablet: Cellulose microcrystalline Tablet coating: Hypromellose 15 cps |
Aceclofenac Tablets 100 mg are packed in aluminium -aluminium blister packs.
The aluminium blister foil is soft temper, plain, one side bright, dull side lacquer laminated to 25 μm OPA, bright side lacquer laminated to 60 μm PVC.
The aluminium foil is 0.025 mm thick aluminium alloy hard temper foil with mat finish.
The blisters are further pack in to carton along with leaflet in pack sizes of 10, 20, 30, 40, 60 and 100 tablets per pack.
Not all pack sizes may be marketed.
Accord Healthcare Limited, Sage House, 319, Pinner Road, North Harrow, Middlesex HA1 4 HF, United Kingdom
PL 20075/0350
14/09/2011
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
